ARCHIVES

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

Nexavar Improves PFS In Phase III Trial

January 25, 2013

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Sanofi Responds to Criticism From Oncologists

November 8, 2012

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990